MANTLE CELL LYMPHOMA

This adverse event was reported 1523 times

These drugs are most commonly taken by patients reporting MANTLE CELL LYMPHOMA:

# Drug Count
0 RITUXIMAB 443
1 IBRUTINIB 406
2 LENALIDOMIDE 267
3 BORTEZOMIB 213
4 VENETOCLAX 206
5 CYCLOPHOSPHAMIDE 174
6 CYCLOPHOSPHAMIDE FOR INJECTION 174
7 CYCLOPHOSPHAMIDE INJECTION, SOLUTION 174
8 PREDNISONE 155
9 CYTARABINE 143
See all common drugs associated with MANTLE CELL LYMPHOMA

MANTLE CELL LYMPHOMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PIRTOBRUTINIB 19 0.0194
1 BREXUCABTAGENE AUTOLEUCEL 37 0.0171
2 GLOFITAMAB 33 0.0122
3 RITUXIMAB-ABBS 40 0.0078
4 BENDAMUSTINE HCL 103 0.0066
5 CARMUSTINE 30 0.0064
6 BENDAMUSTINE HYDROCHLORIDE 51 0.0060
7 IBRITUMOMAB TIUXETAN 9 0.0059
8 ZANUBRUTINIB 23 0.0051
9 IBRUTINIB 406 0.0050
See all drugs enriched for association with MANTLE CELL LYMPHOMA